HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitol

an antidiabetic agent that inhibits sodium-dependent glucose cotransporter 2 (SGLT2); structure in first source
Also Known As:
Lusefi; TS 071; TS-071; TS071 cpd; luseogliflozin
Networked: 96 relevant articles (22 outcomes, 43 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Seino, Yutaka: 16 articles (01/2020 - 07/2014)
2. Sakai, Soichi: 14 articles (11/2018 - 07/2014)
3. Samukawa, Yoshishige: 14 articles (11/2018 - 07/2014)
4. Sasaki, Takashi: 12 articles (01/2019 - 07/2014)
5. Fukatsu, Atsushi: 11 articles (11/2018 - 07/2014)
6. Haneda, Masakazu: 6 articles (11/2018 - 01/2015)
7. Ubukata, Michito: 5 articles (07/2015 - 07/2014)
8. Kojima, Naoki: 4 articles (01/2022 - 06/2013)
9. Inagaki, Nobuya: 4 articles (04/2016 - 01/2015)
10. Kaku, Kohei: 4 articles (04/2016 - 01/2015)

Related Diseases

1. Type 2 Diabetes Mellitus (MODY)
2. Body Weight (Weight, Body)
3. Hyperglycemia
4. Heart Failure
5. Hypertension (High Blood Pressure)

Related Drugs and Biologics

1. Sodium-Glucose Transporter 2 Inhibitors
2. Glucose (Dextrose)
3. Sodium-Glucose Transport Proteins
4. Sodium
5. Blood Glucose (Blood Sugar)
6. voglibose (Basen)
7. Glycoside Hydrolase Inhibitors
8. Guanosine Triphosphate (GTP)
9. Lipids
10. Brain Natriuretic Peptide (Natrecor)

Related Therapies and Procedures

1. Glycemic Control
2. Therapeutics
3. Carbohydrate-Restricted Diet (Low Carbohydrate Diet)
4. Aftercare (After-Treatment)